Functional Analysis & Screening Technologies - Fast Congress

Time 2020-09-23 17:04:02

Web Name: Functional Analysis & Screening Technologies - Fast Congress

WebSite: http://www.fastcongress.com

ID:57178

Keywords:

Screening,Analysis,Functional,

Description:

FAST Congress joins forces withHigh-Content Analysis 3D Screeningfor expanded coverage!November 6-8, 2017 | Cambridge, MAHighContentAnalysis.com Wrapping up its third year, FAST: Functional Analysis Screening Technologies Congress was host to 250+ Drug R D teams dedicated to improving drug screening and safety using 3D cell culture, phenotypic screening, and cancer immunotherapy. Cambridge Healthtech Institute (CHI) would like to thank all the speakers, attendees, sponsors, and exhibitors for their participation. 2015 Event Stats:250+ Delegates from 130+ Companies60 Speakers25 Posters Presented15 Countries Represented14 Exhibiting CompaniesView the 2015 Attendee List Here’s what our attendees had to say about the congress:If you missed our 2015 event, you can reserve a copy of the conference proceedings CD to access the speaker slides and poster abstracts our delegates received on-site. NOVEMBER 10-11, 2015Screening and Functional Analysis of 3D Models Introduction to High-Content Phenotypic ScreeningScreening Strategies for Cancer ImmunotherapyExpert ThinkTank: How to Meet the Need for Physiologically Relevant AssaysCoverage Includes:Organoids and Primary Organotypic 3D Culture in Drug DiscoveryPhenotypic Screening for New Target, Pathway and Mechanism-of-Action DiscoveryPhenotypic Screening Using Primary and Stem Cell-Derived ModelsCase Studies in Phenotypic Drug DiscoveryEngineering Functional Organ-on-a-Chip Models3D Spheroid Models for Drug ScreeningIntegrated Approach to in vitro Drug Discovery: Tissue Engineering Meets Systems BiologyMicroengineered 3D Models for Drug Safety TestingPhenotypic and High-Content Screening of 3D ModelsCancer-on-a-Chip: Engineering 3D Models of Tumor MicroenvironmentFeatured Speakers:Kevin E. HealyProfessor, Bioengineering, University of California, BerkeleyDavid C. SwinneyCEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)Jeffrey MorganProfessor, Medical Science Engineering Brown UniversityDavid GraingerProfessor, Pharmaceutical Chemistry University of UtahSophie A. LelièvreDirector, 3D Cell Culture Core Facility Purdue UniversityAnne BangDirector, Cell-Based Disease Modeling and Screening, Sanford-Burnham-Prebys Medical Discovery InstituteMichael ShenProfessor, Medicine, Systems Biology Columbia UniversityCambridge Healthtech Institute (CHI)Email: juliab@healthtech.comFor sponsorship and exhibit sales information, please contact:Angela ParsonsVP Business DevelopmentCambridge Healthtech Institute (CHI)Phone: (+1) 781-972-5467Email: aparsons@healthtech.comFor media and association partnerships, please contact:James PrudhommeSenior Marketing ManagerCambridge Healthtech Institute (CHI)Phone (+1) 781-972-5486Email: jprudhomme@healthtech.com

TAGS:Screening Analysis Functional 

<<< Thank you for your visit >>>

Hot Websites